Últimas noticias sobre DocuSign (NASDAQ:DOCU) Bolsa

DocuSign

Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in May 2018.

DocuSign Inc

DOCUSIGN ORD

News

Financing

Kite Realty Group Recasts $1.1B Unsecured Revolving Credit Facility And Amends $250M Term Loan Facility

LASE

Laser Photonics Corp Requests That Their Press Release Issued October 1, 2024 Titled "laser Photonics To Supply Cleantech Laser Cleaning Technology To Hemlock Semiconductor" Be Killed; The Release Was Issued In Error By Laser Photonics Corporation. A Replacement Release Will Not Be Issued.

AMERISAFE, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsf#NASDAQ">AMSF</a>) is currently considered expensive on a relative basis, with the stock trading at a 22X forward 12-month price-to-earnings (P/E) ratio, which is at a premium compared with its five-year median of 20.21X and the Zacks&nbsp;Insurance - Accident and Health average of 13.36X. A premium valuation generally indicates that the market has strong confidence in the company&#39;s prospects. However, this necessitates scrutiny to determine if this higher price is warranted.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/a5/80818.jpg?v=1155545738" style="border-style:solid; border-width:1px; height:310px; width:600px" />
Image Source: Zacks Investment Research
In comparison, other insurers like&nbsp;Employers Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eig#NYSE">EIG</a>) and&nbsp;ProAssurance Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pra#NYSE">PRA</a>) are cheaper at 13.30X and 19.72X, respectively.
A brief analysis is needed to determine whether AMSF&#39;s premium valuation is justified based on its growth prospects and fundamentals.
Let&#39;s delve deeper.
Incorporated in 1985 and headquartered in DeRidder, LA, AMERISAFE currently has a market cap of $909.9 million. It is well positioned for growth, leveraging rising investment income and a robust balance sheet.
AMSF&#39;s extensive experience in hazardous industries and a high policy retention rate are major positives. Its cost-saving initiatives are expected to support its bottom line. Last year, it lowered loss and loss adjustment expenses by 2.7%.
The long time lag between receiving premiums and settling claims allows the company to invest funds for extended periods, compounding returns more effectively than insurers with quicker claim payouts, thereby boosting its investment income potential. Last year, it recorded a net investment income of $31.3 million, which advanced by 15.1%, resulting from increased fixed-income reinvestment rates. The first half of 2024 also witnessed higher reinvestment rates.
AMSF&#39;s solid balance sheet, with no debt and $884.2 million in investments and cash as of June 30, 2024, supports initiatives to boost shareholder value. The company raised its quarterly dividend by 8.8% in February 2024, continuing its steady dividend payments since 2013. In the second quarter, AMERISAFE repurchased $4.1 million worth of shares, with $6.3 million remaining in its buyback program as of June 30.
<h2>Should Investors Pay the Premium for AMSF?</h2>
The factors mentioned above have contributed to AMERISAFE&#39;s premium valuation, reflecting strong investor confidence in its future growth and profitability. As a result, investors are willing to pay a higher price for the stock, anticipating that it will outperform both its industry peers and the broader market in the coming months.
However, uncertainty surrounds the stock due to AMERISAFE&#39;s continuous decline in net premiums earned over the past five years. If this trend persists, it could potentially impede the company&#39;s ability to enhance its profits. The Zacks Consensus Estimate for 2024 earnings is pegged at $2.40 per share, indicating a 17.5% year-over-year decline. The same for 2025 signals a further 12.5% fall.
Also, AMERISAFE has faced a downward trend in free cash flow from 2018 to 2022, indicating potential operational challenges. While it saw a 12.2% increase in 2023, the sustainability of this growth is uncertain. In the trailing 12 months, free cash flow dropped sharply by 56.7%, raising concerns about the company&#39;s long-term financial health.
Despite these headwinds, the company&#39;s overall outlook remains positive. Leading brokers have raised AMSF&#39;s short-term price target by 12.47% from its recent closing price of $47.72, with the highest target set at $65, representing a potential upside of 36.21%.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/06/80819.jpg?v=1182891382" style="border-style:solid; border-width:1px; height:315px; width:600px" />
Image Source: Zacks Investment Research
Existing investors should hold onto AMERISAFE stock to capitalize on its upward price movement. However, new investors might want to wait for a better entry point. Currently, the stock has a Zacks Rank #3 (Hold) and appears overvalued, suggesting that it may not be the ideal time to buy. Waiting for a more attractive valuation could present a better opportunity to invest.
<a href="https://www.zacks.com/stock/news/2347764/is-amerisafe-stock-a-pricey-pick-or-a-hidden-gem-for-your-portfolio?cid=CS-BENZ-FT-analyst_blog|rank_focused-2347764">To read this article on Zacks.com click here.</a>

Earnings

Dividends

Price Target

Buybacks

Small Cap

Markets

Analyst Ratings

Trading Ideas

Insurance

AMSF

Is AMERISAFE Stock a Pricey Pick or a Hidden Gem for Your Portfolio?

In the current session, the stock is trading at $161.40, after a 0.09% spike. Over the past month, Booz Allen Hamilton Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) stock increased by 6.29%, and in the past year, by 27.44%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1728418508_0.png" alt="Past Year Chart" />

<h3>How Does Booz Allen Hamilton P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Booz Allen Hamilton has a lower P/E than the aggregate P/E of 46.25 of the Professional Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1728418508_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

P/E Ratio Insights for Booz Allen Hamilton

VXRT

Vaxart Provided Notice To Sales Agents To Terminate Sales Agreement, Effective Oct 18; Will Not Incur Any Termination Penalties As Result Of Termination

Getting income from stock investments is why many invest in certain companies. It can provide a stable cash stream while offering the benefit of potential appreciation in stock price. However, companies must balance how much they pay their shareholders through dividends and how much they retain to reinvest back in their business.
If a company has valuable projects to pursue but lacks cash, its high dividends could hurt shareholders in the long run. One way to measure a company&#39;s ability to reinvest is to look at the dividend payout ratio (DPR). This ratio shows the percentage of the company&#39;s earnings it pays out as dividends.
If the dividend payout ratio is too high, the company might not have the cash it needs to invest in potentially high-return projects in the future. This could include making large capital expenditures (CAPEX) or strategically acquiring another firm.
The inability to do this could negatively affect the stock price over time or prevent it from rising as much as it otherwise could. Below, I&#39;ll review three U.S. stocks with dividend yields over 5% and dividend payout ratios that allow for solid reinvestment back into their business. For this analysis, I&#39;ll use these companies&#39; next twelve-month (NTM) dividend yield, which is an average of analyst projections for the company&#39;s dividend yield.
<h2>Ford Motor: Lots of Dividend Income and Lots Left Over</h2>
First up is Ford Motor (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/f#NYSE">F</a>). Ford&#39;s NTM dividend yield of 5.6% is relatively high, and its dividend payout ratio over the last twelve months is low. It sits at just 13.8%, meaning that the company is retaining over 86% of its earnings to reinvest back into the firm. Based on the company&#39;s net income over the last twelve months, it has been over $3.3 billion, and the company has to put it toward different uses.
This gives Ford the flexibility to invest in projects, initiate a share buyback program, or increase dividends. This is crucial, as the automotive industry is capital-intensive, requiring significant investments in plants, property, and equipment to stay competitive. With the global shift toward electric vehicles, maintaining financial flexibility will help Ford remain nimble, allowing the company to adapt to market changes and meet evolving customer preferences. This ability to invest strategically is key to Ford&#39;s long-term success in the rapidly changing automotive landscape.
<h2>AT&amp;T: 5% Dividend While Investing Big in Fiber Optics</h2>
AT&amp;T (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/t#NYSE">T</a>) is a telecom company that provides big-time income to its shareholders while not overextending its commitments. Its 5.1% NTM dividend yield offers a solid base of return. Its dividend payout ratio is 64%. It&#39;s a bit higher than I would like to see, but it&#39;s below 75%, where concerns about sustainability may arise. Again, its industry is key to why the company must retain earnings to compete effectively. AT&amp;T is investing heavily in fiber optics to connect more homes and businesses to the Internet.
Building fiber optic networks requires digging trenches on land or underwater or building above-ground cable systems. These cables physically connect buildings to centralized data centers, allowing for faster internet speeds. Thus, these investments require significant CAPEX from AT&amp;T. The company is doing just that, having spent $17.4 billion in CAPEX over the last twelve months. Fiber optics investments are vital to the firm&#39;s strategic plan to compete with large telecom firms.
<h2>Ares Capital&#39;s Dividend Strategy Balances Payouts and Growth Potential</h2>
Last on the list is Ares Capital (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arcc#NASDAQ">ARCC</a>). Ares is a business development company (BDC). BDCs invest in private companies using both debt and equity. Because of this, investing in Ares is an indirect way to gain some exposure to private debt and private equity, making Ares an interesting stock. On top of this, Ares also provides its shareholders a massive dividend yield.
Analysts project the number to sit at just under 9.3% over the next twelve months. In addition, its dividend payout ratio is 63%. Again, maybe a bit on the high side, but Ares is not in an industry that requires much in the way of capital expenditures.
However, retaining more of its net income does allow the company more &quot;dry powder&quot; to invest with. This means that if it sees an opportunity that could bring in particularly high returns but requires a large upfront investment, it could be more capable of executing the deal.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/maximize-your-returns-3-dividend-stocks-with-yields-over-5/">Maximize Your Returns: 3 Dividend Stocks With Yields Over 5%</a>&quot; first appeared on MarketBeat.

Large Cap

Offerings

ARCC

Maximize Your Returns: 3 Dividend Stocks With Yields Over 5%

DA Davidson analyst Peter Heckmann maintains Euronet Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEFT#NASDAQ">EEFT</a>) with a Buy and maintains $136 price target.

EEFT

DA Davidson Maintains Buy on Euronet Worldwide, Maintains $136 Price Target

DA Davidson analyst Brent Thielman maintains Apogee Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APOG#NASDAQ">APOG</a>) with a Neutral and raises the price target from $65 to $75.

APOG

DA Davidson Maintains Neutral on Apogee Enterprises, Raises Price Target to $75

WIIM

CRDL

Cardiol Therapeutics shares are trading lower after the company announced a preliminary prospectus for a proposed public offering of common stock, size or amount not disclosed.

The new platform fundamentally changes how the company builds products and will provide expanded commerce capabilities like Pre-Auth and Bar Tabs to sellers of all sizes across verticals in the U.S.

Square Reports General Availability Of New Orders Platform

Management

SANA

Sana Biotechnology Announces Susan Wyrick Appointed Interim CFO Of Co

Crocs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crox#NASDAQ">CROX</a>) stock seems in a good spot since the past year, with shares rising more than 60%, comfortably outperforming the broader Consumer Discretionary sector&#39;s return of 18.5% and the Zacks Textile - Apparel industry&#39;s growth of 4.8% in the same period. CROX&#39;s shares have also surpassed the S&amp;P 500 index&#39;s appreciation of 34.3% in a year.
Currently priced at $136.54, CROX stock is trading at 17.4% to its 52-week high of $165.32, reached on June 20, 2024. However, it is trading at an 84.5% premium to its 52-week low mark.
<h2>CROX&#39;s Strategies Aid the Rally</h2>
The company has been gaining from solid consumer demand across its Crocs and HEYDUDE brands, backed by effective pricing actions. Strength in clogs, sandals and personalization is acting as a tailwind. CROX has built various successful franchises, focused on expanding new usage occasions to boost new and repeat purchases. The sandal category further strengthened as consumers gave positive feedback to its innovation.
Management continues to view personalization as a mega consumer trend, with the opportunity of expanding the Jibbitz penetration in 2024 via higher penetration within digital and wholesale channels, continuous product freshness innovation and advancement in market capabilities. The company has been evolving its partnership model to boost engagement and consumer love.
<h2>CROX&#39;s Price Performance</h2>
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c6/80801.jpg?v=1226149498" />
Image Source: Zacks Investment Research
Crocs aims at solidifying the business in North America and developing Wendy and Wally as iconic franchises. The company brought new HEYDUDE partnerships to the market, which include Corona, a four-piece collection with the iconic beverage band, featuring Wally, Wendy and Hudson Styles. Its Lee partnership, Denim and Dudes, highlighted the first HEYDUDE collaboration with international reach.
Crocs is on track with its long-term strategy and key initiatives to deliver sustainable growth. Its growth strategy is focused on three key initiatives. The first key initiative is igniting icons to enhance brand awareness and relevance. The second is investing strategically in Tier 1 markets to drive market share gains via talent, marketing, digital and retail. The third initiative is diversifying the product range to attract new consumers.
<h2>Earnings Estimate Revisions Favor Crocs</h2>
The aforesaid catalysts have prompted analysts to remain optimistic about CROX. The Zacks Consensus Estimate for 2024 and 2025 earnings has been northbound. In the past 30 days, the consensus estimate for earnings per share has been revised 0.3% to $12.88 for 2024 and 0.2% to $14.00 for 2025.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c6/80815.jpg?v=687041234" />
Image Source: Zacks Investment Research
<h2>Unlocking CROX Stock&#39;s Valuation</h2>
Crocs stock is trading at an attractive valuation relative to the industry. Going by the price/earnings ratio, CROX&nbsp; is currently trading at 9.91 on a forward 12-month basis, lower than 12.68 of the industry. Also, the stock is trading lower than the S&amp;P 500 index&#39;s 21.69.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c6/80814.jpg?v=1442318185" />
Image Source: Zacks Investment Research
<h2>Final Words on CROX</h2>
CROX stock is performing well on the bourses given its solid strategic efforts including strength in its brands. Solid upward revisions in earnings estimates and attractive valuation for the stock seem encouraging as well.
To wrap up, Crocs seems to be an attractive investment bet given all the aforementioned positives. The company currently sports a Zacks Rank #1 (Strong Buy).
<h2>Other Solid Picks</h2>
We have highlighted three other top-ranked stocks, namely, G-III Apparel Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/giii#NASDAQ">GIII</a>), Royal Caribbean (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rcl#NYSE">RCL</a>) and lululemon athletica (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lulu#NASDAQ">LULU</a>).
G-III Apparel is a manufacturer, designer and distributor of apparel and accessories under licensed brands, owned brands and private label brands. It sports a Zacks Rank of 1 at present.
GIII Apparel has a trailing four-quarter earnings surprise of 118.2%, on average. The Zacks Consensus Estimate for GIII Apparel&#39;s current financial-year sales indicates growth of 3.3% from the year-ago figure.
Royal Caribbean carries a Zacks Rank #2 (Buy) at present. RCL has a trailing four-quarter earnings surprise of 18.5%, on average.
The Zacks Consensus Estimate for RCL&#39;s 2024 sales and EPS indicates an increase of 18.2% and 70.9%, respectively, from the year-ago levels.
lululemon athletica is a yoga-inspired athletic apparel company. LULU carries a Zacks Rank of 2 at present.
The Zacks Consensus Estimate for lululemon athletica&#39;s current financial-year sales and EPS indicates growth of 9.2% and 9.8%, respectively, from the year-ago corresponding figures. LULU has a trailing four-quarter earnings surprise of 7.9%, on average.
<a href="https://www.zacks.com/stock/news/2347760/crocs-gains-on-brand-strength-other-efforts-apt-to-stay-invested?cid=CS-BENZ-FT-analyst_blog|rank_focused-2347760">To read this article on Zacks.com click here.</a>

Mid Cap

CROX

GIII

LULU

Crocs Gains on Brand Strength & Other Efforts: Apt to Stay Invested?

Shipping in pre-production quantities, Scorpio Smart Fabric Switches deliver maximum system utilization and uptime for scale-out PCIe 6 connectivity and scale-up GPU clustering in AI servers
Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced a new portfolio of fabric switches, including the industry's first PCIe&#xAE; 6 switch, built from the ground up for demanding AI workloads in accelerated computing platforms deployed at cloud-scale. The Scorpio Smart Fabric Switch portfolio is optimized for AI dataflows to deliver maximum predictable performance per watt, high reliability, easy cloud-scale deployment, reduced time-to-market, and lower total cost of ownership.

ALAB

Astera Labs Introduces New Portfolio Of Fabric Switches Purpose-Built For AI Infrastructure At Cloud-Scale

DA Davidson analyst Michael Baker maintains Superior Gr of Cos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGC#NASDAQ">SGC</a>) with a Buy and maintains $24 price target.

DA Davidson Maintains Buy on Superior Gr of Cos, Maintains $24 Price Target

ImmuCell Corporation (Nasdaq:&nbsp;ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today&nbsp;announced preliminary, unaudited sales results for the third quarter of 2024, which ended September 30, 2024.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="6">Preliminary, Unaudited Total Sales Results: &nbsp;</td>
</tr>
<tr>
<td>2024</td>
<td>2023</td>
<td colspan="2">$ Increase</td>
<td colspan="1">% Increase</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>During the Three-Month Periods Ended September 30,</td>
<td>$6.0 million</td>
<td>$5.4 million</td>
<td colspan="2">$615,000</td>
<td>11%</td>
</tr>
<tr>
<td>During the Nine-Month Periods Ended September 30,</td>
<td>$18.7 million</td>
<td>$12.4 million</td>
<td colspan="2">$6.4 million</td>
<td>51%</td>
</tr>
<tr>
<td>During the Twelve-Month Periods Ended September 30,</td>
<td>$23.8 million</td>
<td>$16.3 million</td>
<td colspan="2">$7.6 million</td>
<td>46%</td>
</tr>
</tbody>
</table>
</figure>
 During the three-, nine- and twelve-month periods ended September 30, 2024, annualized production output was approximately 73%, 81% and 77%, respectively, of the Company's estimated full capacity of approximately $30 million per year.
As of September 30, 2024, the backlog of orders aggregated approximately $7.3 million. The Company believes that the current backlog reflects strong demand as distributors work to replenish their buffer stocks and as end-users place orders in advance of the first quarter calving season.
Since the first quarter of 2020, the Company has been providing a preliminary look at its unaudited top line results soon after the close of the quarter. The Company expects to continue providing this prompt, preliminary report on product sales until further notice going forward.

Guidance

ICCC

ImmuCell Announces Preliminary Q3 Revenue Of $6M Up From $5.4M YoY

Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $0.94 by 41.49 percent. The company reported quarterly sales of $43.003 million which beat the analyst consensus estimate of $37.124 million by 15.84 percent. This is a 21.09 percent increase over sales of $35.514 million the same period last year.

Earnings Beats

Saratoga Investment Q2 2025 Adj. EPS $1.33 Beats $0.94 Estimate, Sales $43.003M Beat $37.124M Estimate

MYGN

Myriad Genetics Reveals Series Of Ongoing Research Collaborations To Study Use Of Molecular Residual Disease Testing In Breast Cancer Using Precise MRD Test

—Data Presented at the CHEST 2024 Annual Meeting—
BRIDGEWATER, N.J., Oct. 8, 2024 /PRNewswire/ -- Insmed Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today presented positive late-breaking subgroup data from the Phase 3 ASPEN study, a global, randomized, double-blind, placebo-controlled Phase 3 study to assess the efficacy, safety, and tolerability of brensocatib in patients with non-cystic fibrosis bronchiectasis. Posters with the details from these subgroup analyses can be found <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4272617-1&amp;h=1623866854&amp;u=https%3A%2F%2Finvestor.insmed.com%2Fevents%3Fitem%3D127&amp;a=HERE">HERE</a>. These data were presented at the CHEST 2024 Annual Meeting, held October 6-9 in Boston, along with several other presentations from across Insmed's respiratory portfolio.

Biotech

General

INSM

Insmed Inc Presents New Subgroup Analyses From Landmark Phase 3 ASPEN Study Of Brensocatib In Patients With Bronchiectasis Demonstrate Consistency With Overall Trial Population Results At The CHEST 2024 Annual Meeting

Delek Logistics Partners, LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKL#NYSE">DKL</a>) ("Delek Logistics") announced today that it has commenced an underwritten public offering of $150,000,000 of common units representing limited partner interests in Delek Logistics pursuant to an effective shelf registration statement previously filed with the Securities and Exchange Commission (the "SEC"). A preliminary prospectus supplement relating to the offering will also be filed with the SEC. Delek Logistics intends to grant the underwriters a 30-day option to purchase up to an additional $22,500,000 of common units. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Delek Logistics intends to use the net proceeds from the offering (including any net proceeds from the underwriters' exercise of their option to purchase additional common units) to redeem its outstanding convertible preferred units and to repay outstanding borrowings under its revolving credit agreement.
Avigal Soreq, our President and Chief Executive Officer, and certain other of our executives (collectively, the "Executives"), have indicated an interest in purchasing up to $300,000 of the common units offered in the offering at the price offered to the public. Because this indication is not a binding agreement or commitment to purchase, the Executives may elect not to purchase any units in the offering, or the underwriters may elect not to sell any units in the offering to the Executives.

Delek Logistics Partners, LP Announces $150M Proposed Public Offering Of Common Units

Cardiol Therapeutics Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/CRDL#NASDAQ">CRDL</a>) (TSX:<a href="https://www.benzinga.com/stock/CRDL#TSX">CRDL</a>) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce the Company has filed a preliminary prospectus supplement (the "Supplement") to its short form base shelf prospectus dated July 12, 2024 (the "Base Prospectus") in connection with a proposed public offering (the "Offering") of Class A common shares (the "Common Shares"). The Supplement was also filed with the U.S. Securities Exchange and Commission (the "SEC"), as part of a registration statement on Form-10, as amended, which was declared effective by the SEC on July 16, 2024, in accordance with the Multijurisdictional Disclosure System established between Canada and the United States.
The Company intends to use the net proceeds from the Offering to support the clinical development of CardiolRx for the treatment of recurrent pericarditis, and for general and administrative expenses, working capital and other expenses.
Canaccord Genuity is acting as the sole bookrunner in connection with the Offering.

Cardiol Therapeutics Files Preliminary Prospectus Supplement For Proposed Public Offering Of Common Shares; No Size Or Amount Disclosed

Software-as-a-service (SaaS) industry is thriving owing to its versatility, cost-effectiveness, ease of access, and increased investments. Hence, investors could add Smartsheet (SMAR), CCC Intelligent Solutions (CCCS), and DocuSign (DOCU) to their portfolios, as these stocks show great growth potential. Read on… Software-as-a-service or SaaS leads in cloud computing for its versatility, scalability, cost-effectiveness, seamless integration, global accessibility, and customer support. Modern enterprises rely on SaaS for efficiency and innovation, benefiting from its adaptability, collaborative tools, and robust security.
Given the ongoing digital transformation, investors may want to closely monitor strong SaaS stocks Smartsheet Inc. (<a href="https://stocknews.com/stock/SMAR/">SMAR</a>), CCC Intelligent Solutions Holdings Inc. (<a href="https://stocknews.com/stock/CCCS/">CCCS</a>), and DocuSign, Inc. (<a href="https://stocknews.com/stock/DOCU/">DOCU</a>). These companies seem well-positioned to capitalize on the expanding opportunities in the sector.
Cloud-based software services are now dominating over traditional software applications. Enterprises are investing in digital transformation, adopting trends like Vertical SaaS, DaaS, and iPaaS to enhance system connectivity, manage data effectively, and meet rising industry needs.
Hence, Gartner predicts SaaS spending will grow by 20% this year, <a href="https://www.gartner.com/en/newsroom/press-releases/2024-05-20-gartner-forecasts-worldwide-public-cloud-end-user-spending-to-surpass-675-billion-in-2024#:~:text=SaaS%20spending%20is%20projected%20to,consumption%20model%2C%E2%80%9D%20said%20Nag.">reaching $247.20 billion</a>. Supporting this growth, the <a href="https://federalnewsnetwork.com/acquisition-policy/2024/03/gsa-aims-to-make-buying-saas-easier-through-new-policy/?readmore=1">General Services Administration's policy change</a> enables governments to more easily adopt software through upfront payments, strengthening market stability and attracting greater investment opportunities in the expanding SaaS landscape.
Looking forward, according to a report published by Research and Markets, the global SaaS market is projected to grow at a <a href="https://www.researchandmarkets.com/reports/5939098/software-service-saas-global-market-report">CAGR of 6.2%</a>, reaching $325.84 billion by 2028, reflecting its dynamic growth and innovation potential.
Given the SaaS industry's positive trends, let's dive deeper into the fundamentals of three growth-heavy <a href="https://stocknews.com/category/software-saas/">Software – SAAS</a> stocks starting with #3.
Stock #3: Smartsheet Inc. (<a href="https://stocknews.com/stock/SMAR/">SMAR</a>)
SMAR provides a work management platform for organizations, allowing them to plan, capture, manage, automate, and report on work at scale. The cloud-based software is delivered globally through a subscription model, offering products like Smartsheet, WorkApps, and Premium Apps and Connectors for business work management needs.
On July 9, SMAR <a href="https://investors.smartsheet.com/news/news-details/2024/Smartsheet-Integrates-Amazon-Q-on-AWS-to-Implement-New-Generative-AI-Powered-Assistant-for-its-Employees/default.aspx">introduced Amazon Q Business</a>, an AI-powered assistant aimed at enhancing knowledge management and boosting productivity within its cloud operations. The implementation underscores SMAR's commitment to leveraging cutting-edge technology to improve employee efficiency and elevate customer service standards.
On May 14, SMAR unveiled <a href="https://investors.smartsheet.com/news/news-details/2024/Smartsheet-Empowers-Enterprises-to-Make-Smart-Decisions-and-Get-Results-Faster-with-Updates-to-its-Next-Generation-Work-Management-Platform/default.aspx">new AI and resource management features</a>, offering businesses actionable insights and improved operational visibility. In the rapidly growing AI sector, SMAR continues to solidify its market presence by integrating advanced technologies that support business growth and innovation across industries.
During the fiscal 2025 second quarter that ended July 31, 2024, SMAR's total revenue increased 17.3% year-over-year to $276.41 million. Its non-GAAP operating income rose 135.7% from the year-ago value to $45.30 million.
Moreover, the company's non-GAAP net income and non-GAAP net income per share grew 180% and 175% from the prior year's quarter to $61.64 million and $0.44, respectively.
Analysts expect SMAR's revenue and EPS for the fiscal 2025 third quarter (ending October 2024) to grow 15.4% and 90.3% year-over-year to $283.85 million and $0.30, respectively. Also, the company has topped the consensus revenue and EPS estimates in each of the trailing four quarters, which is impressive.
Shares of SMAR have gained 16.4% over the past three months and 21.1% over the past six months to close the last trading session at $50.56.
SMAR's bright prospects are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
SMAR has an A grade for Growth and Sentiment and a B for Quality. It is ranked #5 out of 18 stocks in the A-rated <a href="https://stocknews.com/category/software-saas/">Software – SAAS</a> industry.
To see SMAR's Value, Momentum, and Stability ratings, <a href="https://stocknews.com/stock/SMAR/">click here</a>.
Stock #2: CCC Intelligent Solutions Holdings Inc. (<a href="https://stocknews.com/stock/CCCS/">CCCS</a>)
CCCS provides software-as-a-service (SaaS) platform for the property and casualty (P&amp;C) insurance economy. The company's cloud-based software serves as a service platform connecting trading partners, facilitating commerce, and enabling digital workflow across the platform through artificial intelligence.
On September 4, CCCS <a href="https://ir.cccis.com/news-releases/news-release-details/ccc-launches-cccr-payroll-streamline-payroll-management">launched CCC&#xAE; Payroll</a>, a solution to streamline payroll management for collision repair shops. By integrating this into the CCC ONE&#xAE; Platform, CCCS enhances operational efficiency for businesses. The innovation could strengthen CCCS' market position, driving customer adoption and fostering growth.
On July 30, CCCS <a href="https://ir.cccis.com/news-releases/news-release-details/ccc-launches-cccr-intelligent-reinspection-help-auto-insurers">introduced CCC&#xAE; Intelligent Reinspection</a>, which uses AI to streamline auto insurers' repair estimate reviews. By automating and simplifying workflows, CCCS is tapping into the AI revolution, helping secure a larger market share and paving the way for further expansion and technological advancement.
CCCS' revenues for the fiscal 2024 second quarter that ended June 30, 2024, increased 9.9% year-over-year to $232.62 million. It reported an adjusted gross profit of $182.08 million, indicating a 12.4% growth from the prior year quarter with an adjusted gross profit margin of 78%.
In addition, the company's <a href="https://www.investopedia.com/ask/answers/010715/what-being-adjusted-adjusted-net-income.asp">adjusted net income</a> came in at $56.19 million or $0.09 per share, up 17.4% and 28.6% year-over-year, respectively. Also, its adjusted EBITDA increased 18.4% year-over-year, amounting to $95.79 million.
The consensus revenue and EPS estimates of $237.36 million and $0.09 for the fiscal third quarter (ending September 2024) represent a 7.3% and 2% year-over-year increase, respectively. Moreover, CCCS has an impressive surprise history; it surpassed the expected revenue and EPS estimates in each of the four trailing quarters.
The stock has gained 5.8% over the past month to close the last trading session at $10.75.
CCCS' POWR Ratings reflect its promising outlook. The stock has an overall rating of B, which equates to Buy in our proprietary rating system.
CCCS has a B grade for Growth, Stability, and Sentiment. It is ranked #3 out of 18 stocks in the Software – SAAS industry.
<a href="https://stocknews.com/stock/CCCS/">Click here</a> to see the other ratings of CCCS for Value, Momentum, and Quality.
Stock #1: DocuSign, Inc. (<a href="https://stocknews.com/stock/DOCU/">DOCU</a>)
DOCU offers electronic signature products, allowing agreements to be signed globally from various devices. The company's products include eSignature, Contract Lifecycle Management, Gen for Salesforce, Identify and Monitor, and Document Generation.
On June 4, DOCU <a href="https://investor.docusign.com/investors/press-releases/press-release-details/2024/Docusign-Introduces-New-Connector-for-SAP-Ariba-Solutions-at-SAP-Sapphire/default.aspx">announced a new Connector</a> for SAP Ariba solutions, automating workflows between DOCU's CLM and SAP Ariba to streamline the source-to-pay process. Available globally in September, this innovation solidifies DOCU's leadership in e-signature technology and strengthens its market presence.
On May 31, DOCU <a href="https://investor.docusign.com/investors/press-releases/press-release-details/2024/Docusign-Completes-Acquisition-of-Lexion-to-Accelerate-Intelligent-Agreement-Management/default.aspx">completed its acquisition</a> of Lexion, an AI-powered agreement management company. The strategic move would enhance DOCU's Intelligent Agreement Management (IAM) capabilities, allowing DOCU to offer advanced AI-assisted solutions and further solidify its position in the rapidly growing IAM space.
DOCU's total revenues for the fiscal 2025 second quarter that ended July 31, 2024, rose 7% year-over-year to $736.03 million. The company's non-GAAP income from operations stood at $236.16 million, up 39.6% from the previous year's quarter.
Additionally, DOCU's non-GAAP net income came in at $200.99 million and $0.97 per share, representing increases of 34.3% and 34.7% year-over-year, respectively.
Street expects DOCU's revenue and EPS for the fiscal 2025 third quarter (ending October 2024) to increase 6.4% and 10.2% year-over-year to $745.31 million and $0.87, respectively. Additionally, the company surpassed the consensus EPS estimates in each of the trailing four quarters, which is impressive.
Shares of DOCU have gained 10.1% over the past three months and 21.8% over the past year to close the last trading session at $56.49.
DOCU's POWR Ratings reflect strong prospects. The stock has an overall rating of A, translating to a Strong Buy in our proprietary rating system.
DOCU has an A grade for Quality and a B for Value and Growth. It has topped the Software – SaaS industry.
Beyond what we stated above, we have also given DOCU grades for Momentum, Stability, and Sentiment. Get all the DOCU's ratings <a href="https://stocknews.com/stock/DOCU/">here</a>.
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>

<hr />
DOCU shares rose $1.29 (+2.28%) in premarket trading Friday. Year-to-date, DOCU has declined -4.98%, versus a 18.37% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Aanchal Sugandh</h2> <img src='https:/wp-content/uploads/2022/12/Aanchal-Sugandh_Headshot.jpg' style="float:left; padding:5px;width:125px;">Aanchal's passion for financial markets drives her work as an investment analyst and journalist. She earned her bachelor's degree in finance and is pursuing the CFA program.

She is proficient at assessing the long-term prospects of stocks with her fundamental analysis skills. Her goal is to help investors build portfolios with sustainable returns.<a href="https://stocknews.com/authors/?author=aanchal-sugandh">More...</a>The post <a href=https://stocknews.com/news/docu-smar-cccs-3-growth-stocks-in-the-saas-space-that-are-set/>3 Growth Stocks in the SaaS Space That Are Set to Soar</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Growth Stocks in the SaaS Space That Are Set to Soar

Palantir Technologies (PLTR) delivered robust financial results and expanded operations through strategic partnerships and multi-year contracts in the second quarter. While the company's growing product demand, strategic initiatives, and innovations contribute to its continued growth, the stock is at an elevated valuation. So, let's determine whether Palantir is an ideal addition to your portfolio. Read more to find out... Palantir Technologies Inc. (<a href="https://stocknews.com/stock/PLTR/">PLTR</a>) builds and deploys software platforms for the intelligence community to help with counterterrorism investigations and operations. In the last reported quarter, the company surpassed analyst revenue and earnings expectations. PLTR reported revenue of $678.13 million, topping analysts' estimate of $652.42 million, and its EPS of $0.09, which also surpassed analysts' estimates.
Palantir caters to a wide range of customers, including government and other commercial organizations. During the second quarter, its US government revenue showed growth of 24% year-over-year to $278 million, and its commercial revenue grew 33% year-over-year to $307 million. Also, the company finalized 27 deals worth over $10 million, and its customer count rose 41% year-over-year.
In the recent period, PLTR entered into multiple strategic partnerships with companies, including Microsoft (<a href="https://stocknews.com/stock/MSFT/">MSFT</a>), BP (<a href="https://stocknews.com/stock/BP/">BP</a>), and Tree Energy Solutions, to accelerate their AI-integrated solutions and operations. Also, the company has contracted to provide data integration and AI solutions to drive digital transformation for customers.
PLTR is among the enterprises that have benefitted exponentially from the Artificial Intelligence (AI) revolution. Last year, it launched its Artificial Intelligence Platform (AIP), which has helped the company achieve faster sales growth. Also, with the solid growth trajectory of the Artificial Intelligence market, poised to grow at a <a href="https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-market-74851580.html">CAGR of 35.7%</a> to reach $1.34 trillion by 2030, Palantir's prospects are promising.
However, rising competition and an increasing number of companies engaged in software development and innovations might affect PLTR's market share and current market dominance.
Shares of PLTR have surged 41.3% over the past six months and 123.9% over the past year to close its last trading session at $34.91.
Let's look at factors that could influence PLTR performance in the upcoming months.
Positive Recent Developments
On September 9, PLTR and BP extended their strategic relationship by entering into an enterprise agreement to introduce new artificial intelligence capabilities through Palantir's AIP software. The new contract is built on a decade of deep collaboration that has created a firm foundation for BP's oil and gas production operations using PLTR's industry-leading software.
Through the collaboration, Palantir's AIP software will help BP harness large language models (LLMs) to enhance and accelerate human decision-making with suggested courses of action through automated analysis of the underlying data.
On August 8, PLTR and Microsoft Corporation announced a significant advancement in their partnership to bring sophisticated and secure cloud, AI, and analytics capabilities to the U.S. Defense and Intelligence Community.
This first-of-its-kind integrated technology enables critical national security missions to operationalize Microsoft's best-in-class LLMs through Azure OpenAI (AOAI) Service within PLTR's AI Platform in Microsoft's government and classified cloud environments.
Robust Financials
For the second quarter that ended June 30, 2024, PLTR's revenue increased 27.1% year-over-year to $678.13 million, and its gross profit rose 17.1% year-over-year to $549.57 million. The company's adjusted income from operations of $253.57 million reflects growth of 87.8% from the year-ago value.
In addition, the company's adjusted net income attributable to common stockholders and adjusted EPS came in at $221.41 million and $0.09, up 85.2% and 80% from the prior year's quarter, respectively. PLTR's <a href="https://www.investopedia.com/terms/a/adjusted-ebitda.asp">adjusted EBITDA</a> increased 82.4% year-over-year to $261.62 million.
Also, the company's adjusted free cash flow improved 54.8% from the prior-year quarter to $148.66 million.
Positive Analyst Estimates
Analysts expect PLTR's revenue for the third quarter (ending September 2024) to grow 26.1% year-over-year to $703.69 million. The consensus EPS estimate of $0.09 for the same period reflects a 29.8% year-over-year improvement. Also, it has an impressive earnings surprise history, having topped consensus revenue and EPS estimates in each of the trailing four quarters.
For the fiscal year ending December 2024, the company's revenue and EPS are expected to grow 24% and 42% year-over-year to $2.76 billion and $0.36, respectively. Additionally, Street expects its revenue and EPS for the fiscal year 2025 to increase 20.3% and 21.4% year-over-year to $3.32 billion and $0.43, respectively.
High Profitability
PLTR's trailing-12-month gross profit margin of 81.39% is 64.2% higher than the industry average of 49.58%. Its trailing-12-month net income margin of 16.32% is significantly higher than the industry average of 3.79%. Further, the stock's trailing-12-month EBIT margin of 11.78% is 134.8% higher than the industry average of 5.02%.
Furthermore, the stock's trailing-12-month ROCE, ROTC, and ROTA of 11.55%, 4.75%, and 7.79% are favorable compared to the industry averages of 4.59%, 2.73%, and 2.17%, respectively.
Elevated Valuation
In terms of forward non-GAAP, PLTR is trading at 98.34x, 320.3% higher than the industry average of 23.39x. Likewise, the stock's forward EV/Sales multiple of 27.01 is considerably higher than the industry average of 2.82. Also, its forward EV/EBITDA of 74.47x is 435.2% higher than the industry average of 13.91x.
Also, the stock's forward Price/Sales of 28.34x is significantly higher than the 2.77x industry average. And its Price/Book of 17.60x is 331.1% higher than the industry average of 4.08x.
POWR Ratings Reflect Uncertainty
PLTR's mixed prospects are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of C, which translates to a Neutral in our proprietary system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
Our proprietary rating system also evaluates each stock based on eight distinct categories. PLTR has an A grade for Quality, consistent with its higher-than-industry profitability.
However, the stock received a D grade for Stability, in sync with its 24-month beta of 2.06.
PLTR is ranked #17 in the 18-stock A-rated <a href="https://stocknews.com/category/software-saas/">Software - SaaS</a> industry.
Beyond what is mentioned above, we have also given PLTR grades for Sentiment, Growth, and Momentum. Get access to all the PLTR Ratings <a href="https://stocknews.com/stock/PLTR/">here</a>.
Bottom Line
PLTR's recent strategic innovations and collaborations with industry leaders have strengthened its position in the AI market. Further, with its continuous efforts of leveraging AI for government and commercial contracts have significantly contributed to the operational expansion.
While the company's long-term prospects appear sturdy with strategic partnerships and solid financial performance, its stretched valuation and rising market competition suggest waiting for a better entry point in this stock could be suitable.
Stocks to Consider Instead of Palantir Technologies Inc. (PLTR)
Due to its near-term uncertain prospects, the odds of PLTR outperforming in the weeks and months ahead are compromised. However, there are many industry peers with much more impressive POWR Ratings. So, consider these A (Strong Buy) or B (Buy) stocks from the A-rated <a href="https://stocknews.com/category/software-saas/">Software - SaaS</a> industry instead:
DocuSign Inc. (<a href="https://stocknews.com/stock/DOCU/">DOCU</a>), MiX Telematics Ltd. ADR (<a href="https://stocknews.com/stock/MIXT/">MIXT</a>), and WM Holding Company, LLC (<a href="https://stocknews.com/stock/MAPS/">MAPS</a>).
For exploring more A and B-rated software stocks, <a href="https://stocknews.com/category/software-saas/">click here</a>.
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>

<hr />
PLTR shares were trading at $35.59 per share on Friday afternoon, up $0.68 (+1.95%). Year-to-date, PLTR has gained 107.28%, versus a 18.99% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/pltr-docu-mixt-maps-msft-bp-does-palantirs-ai-push-make-it-a-buy-now/>Does Palantir's AI Push Make It a Buy Now?</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Does Palantir's AI Push Make It a Buy Now?

Stock moves reflect downgrade for US economic growth outlook - Goldman

DocuSign ($DOCU) emerged as a top performer during the pandemic as demand for remote solutions accelerated the adoption of digital workflows, inclu...

DocuSign (DOCU) Adopts AI and Beats Expectations After Three Years of Decline

UiPath's (PATH) continued growth is fueled by solid demand for its innovative product offerings, strategic innovations, and optimistic analysts' expectations. So, let's analyze whether PATH is a buy today. Read more to find out... UiPath, Inc. (<a href="https://stocknews.com/stock/PATH/">PATH</a>) is a leading enterprise automation and AI software company. It provides an end-to-end automation platform that offers a variety of international robotic process automation (RPA) solutions. In the last reported quarter, the company posted total revenue of $316.25 million, surpassing the analysts' estimate of $303.74 million, and its EPS was $0.04, above the expectations of $0.03.
During the second quarter, the company introduced new platform features to help businesses achieve greater outcomes with AI and automation. These features benefit developers and testers and allow plugins and integration with Copilot for Microsoft 365. Further, UiPath has received industry-wide recognition for its innovations and capabilities.
Daniel Dines, UiPath Founder, and Chief Executive Officer, commented, "Our conversations with customers and partners deepen our conviction that there is an increasing need for AI and automation, and our unwavering commitment to innovation continues to position us as the automation platform of choice for capturing the opportunities that AI brings to an enterprise."
He added, "As we look to the remainder of the year, we will continue to focus on product innovation, customer-centricity, and driving operational efficiencies across the business."
According to the fiscal 2025 third-quarter outlook, PATH expects revenue between $345 million and $350 million. The company's non-GAAP operating income is expected to be approximately $27 million.
For the fiscal full year 2025, the company expects revenue in the range of $1.42 billion to $1.42 billion, and its non-GAAP operating income is expected to be approximately $170 million.
Shares of PATH have declined 4% over the past month to close its last trading session at $12.40.
Let's look at factors that could influence PATH's performance in the upcoming months.
Positive Recent Development
On July 2, PATH announced new features on its platform, which infuse GenAI deeply into the UiPath Business Automation Platform&#x2122; to help businesses achieve greater outcomes with AI and automation. The new features facilitate developers and organizations to build better, faster, and more comprehensive automation.
Robust Financials
PATH's total revenue increased 10.1% year-over-year to $316.25 million during the second quarter that ended July 31, 2024. Its non-GAAP <a href="https://www.investopedia.com/terms/g/grossprofit.asp#:~:text=Gross%20profit%20is%20the%20income,have%20been%20removed%20from%20revenue.">gross profit</a> grew 6.6% from the year-ago value to $263.18 million.
In addition, the company's non-GAAP net income came in at $23.76 million and $0.04 per share for the quarter, respectively. Its non-GAAP adjusted free cash flow increased 25.5% from the year-ago value to $149.78 million.
Also, the company's cash and cash equivalents and total assets stood at $939.31 million and $2.70 billion as of July 31, 2024.
Favorable Analyst Estimates
Analysts expect PATH's revenue for the third quarter (ending October 2024) to increase 6.7% year-over-year to $347.64 million, and its consensus EPS estimate is expected to be $0.07 for the ongoing quarter. Further, the company has maintained an impressive earning surprise history, having surpassed the consensus revenue and EPS estimates in all four trailing quarters.
Additionally, Street expects the company's revenue and EPS for the fiscal year (ending January 2026) to increase 11.5% and 10.5% year-over-year to $1.58 billion and $0.44, respectively.
High Profitability
PATH's trailing-12-month gross profit margin of 84.03% is 69.6% higher than the respective industry average of 49.54%. Its trailing-12-month levered FCF margin of 30.80% is considerably higher than the industry average of 10.36%.
Lower Valuation
In terms of forward non-GAAP PEG, PATH is trading at 0.98x, 48.9% lower than the industry average of 1.92x. Likewise, the stock's forward Price/Book multiple of 3.74 is 14.2% lower than the industry average of 4.36. Also, its forward Price/Cash Flow of 22.14x is lower than the industry average of 22.27x.
POWR Ratings Reflect Promise
PATH's solid prospects are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, translating to a Buy in our proprietary system. The POWR Ratings are calculated by taking into account 118 different factors, with each factor weighted to an optimal degree.
Our proprietary rating system also evaluates each stock based on eight distinct categories. PATH has a B grade for Growth, in sync with its outstanding financial performance in the last reported quarter.
In addition, the stock has a B grade for Quality, consistent with its higher-than-industry profitability.
PATH is ranked #7 in the 18-stock A-rated <a href="https://stocknews.com/category/software-saas/">Software - SAAS</a> industry.
Beyond what I have stated above, we have also given PATH grades for Sentiment, Value, Momentum, and Stability. Get access to all the PATH Ratings <a href="https://stocknews.com/stock/PATH/">here</a>.
Bottom Line
PATH is an enterprise automation and AI software company, and with its consistent innovation strides, it has maintained its leadership with its robotic process automation (RPA) solutions and suite of interrelated software.
Also, owing to its solid financial results, analysts appear bullish regarding the company's long-term growth prospects, driven by robust demand for AI software and solutions, continuous innovations, and expanding operations.
Given PATH's solid financials, accelerating profitability, and promising growth outlook, this software stock could be an ideal buy now.
How Does UiPath Inc. (PATH)) Stack Up Against Its Peers?
While PATH has an overall POWR Rating of B, investors could also check out these other stocks within the <a href="https://stocknews.com/category/software-saas/">Software - SAAS</a> industry with A (Strong Buy) or B (Buy) ratings: DocuSign Inc. (<a href="https://stocknews.com/stock/DOCU/">DOCU</a>), MiX Telematics Ltd. ADR (<a href="https://stocknews.com/stock/MIXT/">MIXT</a>), and CCC Intelligent Solutions Inc. (<a href="https://stocknews.com/stock/CCCS/">CCCS</a>).
For exploring more A and B-rated software stocks, <a href="https://stocknews.com/category/software-saas/">click here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
PATH shares were trading at $12.33 per share on Wednesday afternoon, down $0.07 (-0.56%). Year-to-date, PATH has declined -50.36%, versus a 20.81% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/path-docu-mixt-cccs-is-uipath-a-hidden-gem-in-the-automation-sector/>Is UiPath a Hidden Gem in the Automation Sector?</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Is UiPath a Hidden Gem in the Automation Sector?

DocuSign: Stable Growth Amid Sharp Profit Expansion

DocuSign: A Midcap Worth Considering

DocuSign stock gains on inclusion to S&P Midcap 400 Index

Biggest stock movers today: Chinese stocks, and more

Biggest stock movers today: Robinhood, Chinese names, energy firms and more

AFRM

AMKR

APPF

BEKE

BEPC

BILI

BILL

CAVA

CCCS

CHUY

DASH

DOCU

FTNT

FUTU

HOOD

IONS

IPGP

ITCI

JAZZ

LBRDK

MAPS

MIXT

MNST

MPWR

MSFT

ORCL

PATH

PINS

PLTR

ROKU

SMAR

SMCI

SPXU

TRGP

TRMB

UPRO

VLTO

Contracts

Press Releases

DOCUSIGN ANNOUNCES AGREEMENT TO ACQUIRE LEXION

Docusign Announces Timing of First Quarter Fiscal 2025 Earnings Conference Call

Docusign Completes Acquisition of Lexion to Accelerate Intelligent Agreement Management

Docusign Introduces New Connector for SAP Ariba Solutions at SAP Sapphire

Fintech

Docusign Announces First Quarter Fiscal 2025 Financial Results; Announces $1.0 Billion Increase to Share Repurchase Program

Docusign Announces New Revenue and Engineering Leadership to Help Execute Vision for Intelligent Agreement Management

Docusign Announces Timing of Second Quarter Fiscal 2025 Earnings Conference Call

Docusign Announces Second Quarter Fiscal 2025 Financial Results

Moderne Ventures Closes over $230M for MV Fund III, Scaling its Modern Approach to Venture Investing

DocuSign Set to Join S&P MidCap 400 and MDU Resources Group to Join S&P SmallCap 600

PRCH

SPGI

Altair Engineering Inc. - Class A Common Stock

Altair Engineering

Ansys

AppFolio

Aurora Innovation, Inc. - Class A Common Stock

Aurora Innovation

Aspen Technology

Bentley Systems, Incorporated - Class B Common Stock

Bentley Systems

Dropbox

Dynatrace

Guidewire Software

HashiCorp

HubSpot

Informatica

Samsara

Klaviyo

Manhattan Associates, Inc. - Common Stock

Manhattan Associates

NICE Ltd - American Depositary Shares each representing one Ordinary Share

NICE

Nutanix

Procore Technologies

Smartsheet

SPS Commerce

Tyler Technologies

Unity Software

Zeta Global Holdings Corp. Class A Common Stock

Zeta Global Holdings

Zoom Video Communications, Inc. - Class A Common Stock

Zoom Video Comms

Citigroup

B of A Securities

JMP Securities

RBC Capital

Wells Fargo

DocuSign shares are trading higher after it was announced the company will join the S&P MidCap 400.

Comments

DocuSign

Noticias

Últimas noticias sobre DocuSign (NASDAQ:DOCU) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL